Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring

Clin Mol Hepatol. 2024 Apr;30(2):293-296. doi: 10.3350/cmh.2024.0101. Epub 2024 Feb 19.

Authors

Ying-Nan Tsai^{1

2}, Jia-Ling Wu³, Yao-Chun Hsu^{2

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
² School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
³ Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan.
⁴ Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.

No abstract available

Keywords: Finite antiviral therapy; Hepatitis B core-related antigen; Hepatitis B surface antigen; Time-dependent analysis.

MeSH terms

Antiviral Agents / therapeutic use
DNA, Viral
Hepatitis B Core Antigens
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B virus / genetics
Hepatitis B* / drug therapy
Hepatitis B, Chronic* / drug therapy
Humans

Substances

Antiviral Agents
Hepatitis B Surface Antigens
Hepatitis B Core Antigens
DNA, Viral
Hepatitis B e Antigens

Grants and funding

Gilead Sciences